Diasorin SpA (EUR)
DIA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range164.40 | 170.80
52-Wk Range- | -
Last Close170.50
Mkt Cap (m)9,339.16
Dividend yield0.56
ISINIT0003492391
Volume199,198.00
Exchange VenueMIL

Company Profile

Diasorin SpA is engaged in the development, manufacture and distribution ofimmunodiagnostics and molecular diagnostics tests.

Key Information
Price/Earning50.29
Price/Book10.53
Price/Sales12.69
P/CF38.20
Rev Growth (3 year avg)7.45
EPS Growth (3 year avg)0.16
Operating Margin % 31.50
Net Margin %24.88
Return on Equity22.63
Debt/Equity0.03

Documents

Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.diasoringroup.com

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)443.77499.18569.31637.49669.20706.32
Operating Income (m)131.59156.07177.94197.56209.85222.46
Net Income (m)84.07100.42112.38139.88158.13175.74
Basic EPS1.551.832.052.542.853.21
Avg. Diluted Shares Outstanding (m)54.4054.8855.0955.0055.5154.92
Balance Sheet
EUR201420152016201720182019
Current Assets (m)390.95494.33395.38482.44414.86530.76
Non Current Assets (m)214.74213.57473.24460.48491.08532.79
Total Assets (m)605.69707.91868.62945.72905.941,063.55
Current Liabilities (m)82.1282.44131.88141.12138.45122.48
Total Liabilities (m)------
Total Equity (m)483.37586.81662.82741.42704.73848.62
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)119.85138.45165.60167.44209.88232.67
Capital Expenditure (m)-30.72-32.05-37.43-42.48-52.79-55.79
Figures are quoted in EUR unless stated otherwise
-
No change
170.50
Last Price